Mani Foroohar
Stock Analyst at Leerink Partners
(0.54)
# 4,110
Out of 4,534 analysts
944
Total ratings
44%
Success rate
-1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Initiated Coverage: Buy | $12 | $8.16 | +47.06% | 1 | Jun 4, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $17 | $10.32 | +64.73% | 64 | May 15, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $100 → $154 | $116.62 | +32.05% | 54 | May 15, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Hold | $14 → $2 | $1.87 | +6.95% | 13 | May 8, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $10.92 | +220.51% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $8 → $9 | $3.32 | +171.08% | 7 | Apr 2, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $7 → $11 | $3.43 | +220.70% | 55 | Mar 27, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Hold | n/a | $71.65 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Maintained: Sell | $12 | $59.49 | -79.83% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 → $351 | $272.67 | +28.73% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $100 | $52.95 | +88.86% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $86 | $80.76 | +6.49% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $2 | $0.8182 | +144.44% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $4.55 | +295.60% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $74 | $46.99 | +57.48% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.09 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.89 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $48 | $50.66 | -5.25% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.97 | +67.08% | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.33 | - | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $27 | $15.00 | +80.00% | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.62 | +85.19% | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $37.34 | +87.47% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $2.88 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $4.00 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.2475 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $4.96 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $7.50 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $5.73 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $6.48 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $32.07 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 → $197 | $16.83 | n/a | 3 | Nov 6, 2020 |
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $8.16
Upside: +47.06%
REGENXBIO
May 15, 2026
Maintained: Buy
Price Target: $17
Current: $10.32
Upside: +64.73%
Mirum Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100 → $154
Current: $116.62
Upside: +32.05%
enGene Therapeutics
May 8, 2026
Downgraded: Hold
Price Target: $14 → $2
Current: $1.87
Upside: +6.95%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $10.92
Upside: +220.51%
Camp4 Therapeutics
Apr 2, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $3.32
Upside: +171.08%
Rocket Pharmaceuticals
Mar 27, 2026
Rated: Hold
Price Target: $7 → $11
Current: $3.43
Upside: +220.70%
Arrowhead Pharmaceuticals
Mar 26, 2026
Maintained: Hold
Price Target: n/a
Current: $71.65
Upside: -
Moderna
Feb 11, 2026
Maintained: Sell
Price Target: $12
Current: $59.49
Upside: -79.83%
Alnylam Pharmaceuticals
Dec 15, 2025
Maintained: Hold
Price Target: $370 → $351
Current: $272.67
Upside: +28.73%
Dec 15, 2025
Maintained: Buy
Price Target: $68 → $100
Current: $52.95
Upside: +88.86%
Dec 15, 2025
Maintained: Buy
Price Target: $370 → $86
Current: $80.76
Upside: +6.49%
Dec 15, 2025
Maintained: Buy
Price Target: $3 → $2
Current: $0.8182
Upside: +144.44%
Oct 21, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $4.55
Upside: +295.60%
Oct 15, 2025
Maintained: Buy
Price Target: $56 → $74
Current: $46.99
Upside: +57.48%
Oct 15, 2025
Maintained: Buy
Price Target: n/a
Current: $11.09
Upside: -
Oct 15, 2025
Maintained: Hold
Price Target: n/a
Current: $2.89
Upside: -
Sep 25, 2025
Maintained: Buy
Price Target: $51 → $48
Current: $50.66
Upside: -5.25%
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $11.97
Upside: +67.08%
Sep 3, 2025
Maintained: Buy
Price Target: n/a
Current: $26.33
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $32 → $27
Current: $15.00
Upside: +80.00%
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.62
Upside: +85.19%
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $37.34
Upside: +87.47%
Mar 6, 2025
Maintained: Hold
Price Target: $1
Current: $2.88
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $1
Current: $4.00
Upside: n/a
Jul 15, 2024
Maintained: Buy
Price Target: n/a
Current: $0.2475
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $21
Current: $4.96
Upside: n/a
Jun 8, 2023
Maintained: Sell
Price Target: n/a
Current: $7.50
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $5.73
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $6.48
Upside: n/a
Oct 19, 2021
Maintained: Hold
Price Target: n/a
Current: $32.07
Upside: n/a
Nov 6, 2020
Maintained: Buy
Price Target: $216 → $197
Current: $16.83
Upside: n/a